wy 26703 has been researched along with indoramin in 1 studies
Studies (wy 26703) | Trials (wy 26703) | Recent Studies (post-2010) (wy 26703) | Studies (indoramin) | Trials (indoramin) | Recent Studies (post-2010) (indoramin) |
---|---|---|---|---|---|
11 | 0 | 0 | 237 | 65 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Paciorek, PM; Pierce, V; Shepperson, NB; Waterfall, JF | 1 |
1 other study(ies) available for wy 26703 and indoramin
Article | Year |
---|---|
An investigation into the selectivity of a novel series of benzoquinolizines for alpha 2-adrenoceptors in vivo.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Action Potentials; Animals; Azepines; Chlorisondamine; Clonidine; Female; Indoramin; Methoxamine; Quinolizines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1984 |